The nationwide New Horizons Research Campaign funds promising new cystic fibrosis (CF) research projects in academic and hospital institutions. Supporting research of the highest scientific quality, the NH program also endeavors to fund those applications with the greatest relevance to finding improved treatments or a cure for CF.
Principal Investigators (PIs) must work in their labs to be eligible for funding.
- New Horizons provides a minimum of two $70,000 awards per year for two years via two annual contracts. These awards are based on CFRI’s Research Advisory Committee (RAC) reviewed and designated ‘satisfactory’ progress reports, financial reports, and relevant fund availability to the research project goals.
- Announcement for Letters of Intent (LOI) will be made in September 2021 with the LOI due to CFRI on November 5, 2021 11:59 p.m. EDT from principal investigators for two-year research projects up to $70,000 per year that are highly relevant to CF and are original, probing and/or pioneering a new approach to a therapy or cure. Based on recommendation of the Research Advisory Committee, select applicants will be invited to submit full proposals which are due February 10, 2022 11:59 p.m. EDT.
- Priority is given to proposals of superior scientific quality. This funding opportunity is open to research institutions within the United States. The NH awards also provide seed funding for promising new lines of basic and clinical CF research that show prospects of future funding by other sources, such as the National Institutes of Health (NIH).
Elizabeth Nash Memorial Fellowship
The Elizabeth Nash Memorial Fellowship (ENMF) was inaugurated in 1999 to provide annual funding to Post-Doctoral Fellows engaged in CF-related research at academic and hospital institutions nationwide and encourage collaborative research and communication between the institutions and PI’s. The fellowship is named in memory of geneticist Elizabeth Nash, who had CF and served as CFRI’s RAC Chairperson.
ENMF aims to support new and promising research in critical areas at well-recognized academic and medical laboratories nationwide.
- ENMF supports at least one Post-Doctoral Fellow annually for two years with a grant of $65,000 per year via two annual contracts.
- Yearly award payments are made in two annual $32,500 installments, based on RAC reviewed and designated ‘satisfactory’ project, financial progress reports, and relevant fund availability to the research goals.
- Announcement for Letters of Intent (LOI) will be made in September 2021 with the LOI due to CFRI on November 5, 2021 11:59 p.m. EDT for two-year postdoctoral research fellowships with up to $65,000 per year in basic, clinical or translational research related to cystic fibrosis. Based on recommendation of the Research Advisory Committee, select applicants will be invited to submit full proposals which are due February 10, 2022 11:59 p.m. EDT.
- Up to $65,000 per year will be awarded to a research institution in the United States to support a principal investigator, who in turn appoints a postdoctoral research fellow. Of particular interests are projects that are original, probing and/or pioneering a new approach to a therapy or cure.
Special Circumstance Grants
Projects from researchers at academic and hospital laboratories that fall outside the NH and ENMF criteria and funding cycles may qualify for a Special Circumstance Grant (SCG). SCG grants follow the same rigorous RAC review procedure and are awarded dependent on available grant funding and results of the RAC review.